Beta-O2

Beta o2 Technologiesis a biomedical company, developing the ßAir - Bio-artificial Pancreas, intended to cure Type 1 diabetes. The ßAir offers an immediate source of insulin producing beta cells, to provide the body with insulin on demand. The minimally invasive implantable device, refueled with oxygen via sub-dermally implanted access ports, completely normalized diabetic indicators of glycemic control. BetaO2 offers an innovative and technological approach for a curative strategy that is accessible for all insulin-dependent diabetes patients giving them a regular life liberated from endless precautions and risk complications.